Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RNAZ
#4268
TransCode Therapeutics, Inc. Common Stock
9.830
0
USD
+0.31%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.31%
Mudança mensal
+3.39%
Mudança em 6 meses
+3.39%
Mudança anual
+3.39%
Fechamento anterior
9.800
0
Open
9.750
0
Bid
9.830
0
Ask
9.833
0
Low
9.750
0
High
9.830
0
Volume
9
Mercados
Ações
Cuidados de saúde
RNAZ
Open full chart
Financials
Overview
Relatórios
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.46
21.41
6 285.77
833.62 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
-0.3
-2.31
-3.59
-2.3
-1.34
Return on equity %
-0.34
-5.42
-11.3
8.3
0.01
Return on invested capital %
-10.47 K
-33.53 K
-11.4 K
-23.65 K
-38.24 K
Gross margin %
100
—
—
100
400
Operating margin %
199.58 K
—
—
27.69 K
32.55 K
EBITDA margin %
—
—
—
—
—
Net margin %
222.04 K
—
—
29.62 K
-22.94 K
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
8.97
1.7
1.28
2.56
14.62
Inventory turnover
—
—
—
—
—
Asset turnover
-0
—
—
-0.01
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-462.06 K
899.99 K
-93.3 K
1 045.73
1 874.85
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
1.83 M
284.81 K
14.45 K
456.03
535.65
Net current asset value per share
1.99 M
420.34 K
23 K
557.72
649.03
Tangible book value per share
1.79 M
184.59 K
8 469.62
-158.73
-89.89
Working capital per share
1.77 M
172.71 K
4 980.39
339.78
411.09
Book value per share
1.79 M
184.59 K
8 469.62
-158.73
-89.89
Notícias
TransCode licencia plataforma de terapia para câncer de bexiga da Unleash/n
TransCode licenses bladder cancer therapy platform from Unleash
Ações da TransCode Therapeutics disparam após envio de emenda para IND
Ações da TransCode Therapeutics disparam após estudo promissor sobre glioblastoma
TransCode Therapeutics stock soars after promising glioblastoma study
TransCode Therapeutics appoints Jack E. Stover to board of directors
TransCode e Quantum Leap testarão terapia contra câncer em ensaio de fase 2a
TransCode and Quantum Leap to test cancer therapy in phase 2a trial
TransCode Therapeutics appoints Michel Janicot as development officer
Transcode Therapeutics altera termos de ações preferenciais após aprovação dos acionistas
Transcode Therapeutics amends preferred stock terms following shareholder approval
TransCode reports positive safety data from TTX-MC138 phase 1a trial